Department of Chemistry, Aligarh Muslim University, Aligarh 202002, India.
Colloids Surf B Biointerfaces. 2010 Nov 1;81(1):152-7. doi: 10.1016/j.colsurfb.2010.07.003. Epub 2010 Jul 31.
Clomipramine hydrochloride (CLP) is an antidepressant drug which shows temperature dependent phase separation, also known as the cloud point (CP). Increase in pH decreases the CP of the drug solution. Addition of ureas/thioureas at a fixed pH (6.25) decreases/increases the CP. In ureas, presence of >CO bond causes a decrease in repulsions among positively charged drug molecules. However, >CS bond (of thioureas) behaves oppositely and hence CP increases. Cationic and non-ionic surfactants form mixed micelles and hence increase the CP. Anionic surfactants, at low concentrations, retard micellization and increase the CP. At higher concentrations, these surfactants also form mixed micelles and, due to charge opposite to the drug molecules, reduce the repulsion among micelles and act as CP suppressors. Increase in solution pH/drug concentration at different fixed concentrations of CTAB causes the CP to decrease/increase. Dye solubilization results with the drug have provided proof to the above explanation.
盐酸氯米帕明(CLP)是一种抗抑郁药,具有温度依赖的相分离特性,也称为浊点(CP)。pH 值的增加会降低药物溶液的 CP。在固定 pH 值(6.25)下添加脲/硫脲会降低/增加 CP。在脲中,>CO 键的存在会降低带正电荷的药物分子之间的排斥力。然而,>CS 键(硫脲)的行为相反,因此 CP 增加。阳离子和非离子表面活性剂形成混合胶束,从而增加 CP。阴离子表面活性剂在低浓度下会延迟胶束化并增加 CP。在较高浓度下,这些表面活性剂也会形成混合胶束,由于与药物分子带相反电荷,它们会减少胶束之间的排斥力,并充当 CP 抑制剂。在不同固定浓度的 CTAB 下增加溶液 pH/药物浓度会导致 CP 降低/增加。药物的染料增溶结果为上述解释提供了证据。